Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $90,561 - $119,653
598 Added 49.54%
1,805 $356,000
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $201,737 - $232,673
1,207 New
1,207 $209,000
Q3 2021

Nov 15, 2021

SELL
$189.29 - $209.69 $1.14 Million - $1.26 Million
-6,021 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$155.9 - $187.99 $2.45 Million - $2.95 Million
-15,686 Reduced 72.26%
6,021 $1.12 Million
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $3.13 Million - $3.68 Million
21,707 New
21,707 $3.42 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $79.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Partners Capital Investment Group, LLP Portfolio

Follow Partners Capital Investment Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Partners Capital Investment Group, LLP with notifications on news.